Clinical Research Directory
Browse clinical research sites, groups, and studies.
Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis
Sponsor: Peking University Third Hospital
Summary
This is a single randomised controlled trial. The investigators plan to randomise 800 participants to the levofloxacin plus metronidazole suppositories versus levofloxacin co-administered with metronidazole tablets for the treatment of chronic endometritis in a 1:1 rate. Primary outcome will be the live birth rate after the embryo transfer.
Official title: Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets for the Treatment of Chronic Endometritis: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 42 Years
Study Type
INTERVENTIONAL
Enrollment
800
Start Date
2024-10-22
Completion Date
2026-12-30
Last Updated
2024-10-21
Healthy Volunteers
No
Conditions
Interventions
Levofloxacin Plus Metronidazole Suppositories
Administer a two-week course of Levofloxacin Plus Metronidazole Suppositories to patients diagnosed with chronic endometritis.
Levofloxacin co-administered with Metronidazole tablets
Administer a two-week course of Levofloxacin in combination with Metronidazole tablets to patients diagnosed with chronic endometritis.
Locations (1)
Peking university third hospital
Beijing, China